For weight loss, healthcare professionals may prescribe GLP-1 receptor agonists if you have a starting body mass index (BMI) of 30 or higher or if you have a BMI of 27 or higher and at least 1 weight-related health condition, including: Type 2 diabetes Cardiovascular disease High blood pressure High cholesterol Liver disease Polycystic ovary syndrome Obstructive sleep apnea What are the common side effects of GLP-1 receptor agonists
Melanotan 1 (afamelanotide, brand name Scenesse) selectively targets MC1R for tanning with fewer side effects and is approved in the EU for erythropoietic protoporphyria
This guide covers the pharmacology, the clinical trial data, the side effects, the costs, and the practical considerations that should inform your conversation with a healthcare provider
The researchers found that the nutrient caused an increased risk of thrombosis (blood clots) in their participants
Not suitable for phenylketonurics
Individual results vary significantly from mean values shown in the calculator